Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Strict blood glucose control with Actrapid to prevent atrial fibrillation after CABG
2004-004348-39Phase 4Completed
- Sponsor
- Royal Brompton and Harefield hospitals
- Start
- May 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of human insulin in Atrial fibrillation (AFib), coronary arteriosclerosis, sponsored by Royal Brompton and Harefield hospitals. Started May 2005; status: completed.
02
Drugs
human insulin
03
Conditions
Atrial fibrillation (AFib)coronary arteriosclerosis
Beyond the preview
Go deeper on 2004-004348-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004348-39.